Application of single-cell RNA sequencing in optimizing a combinatorial therapeutic strategy in metastatic renal cell carcinoma
暂无分享,去创建一个
David G. Kirsch | Yoojin Shin | Do-Hyun Nam | Woong-Yang Park | Kyu-Tae Kim | D. Nam | W. Park | D. Kirsch | Hae-Ock Lee | Yoojin Shin | B. Jeong | H. Lee | K. Joo | Kyeung Min Joo | Hae-Ock Lee | Hye Won Lee | Hye Jin Song | Da Eun Jeong | Sang Shin | Hyunho Kim | Byong Chang Jeong | D. Jeong | H. Song | S. Shin | Kyu‐Tae Kim | Hyunho Kim
[1] Huanming Yang,et al. Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor , 2012, Cell.
[2] Philippe Dessen,et al. Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer , 2012, Clinical Cancer Research.
[3] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[4] A. Bouchard-Côté,et al. PyClone: statistical inference of clonal population structure in cancer , 2014, Nature Methods.
[5] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer , 2011, Nature Biotechnology.
[6] E. S. Venkatraman,et al. A faster circular binary segmentation algorithm for the analysis of array CGH data , 2007, Bioinform..
[7] L. Truong,et al. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison. , 2012, Archives of pathology & laboratory medicine.
[8] Jing Yang,et al. Epithelial–mesenchymal plasticity in carcinoma metastasis , 2013, Genes & development.
[9] G. Keating. Afatinib: A Review of Its Use in the Treatment of Advanced Non-Small Cell Lung Cancer , 2014, Drugs.
[10] Charles J. Vaske,et al. Single-cell analyses of transcriptional heterogeneity during drug tolerance transition in cancer cells by RNA sequencing , 2014, Proceedings of the National Academy of Sciences.
[11] N. McGranahan,et al. The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.
[12] C. Klein,et al. Parallel progression of primary tumours and metastases , 2009, Nature Reviews Cancer.
[13] J. Cheville,et al. Clear Cell Renal Cell Carcinoma: Gene Expression Analyses Identify a Potential Signature for Tumor Aggressiveness , 2005, Clinical Cancer Research.
[14] E. Lander,et al. Erratum: Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudinlow and metaplastic breast cancer subtypes (Proceedings of the National Academy of Sciences of the United States of America (2010) 107:35 (15449-15454)) , 2010 .
[15] S. Ramaswamy,et al. Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.
[16] Y. Okada,et al. Invasion and metastasis of renal cell carcinoma , 2014, Medical Molecular Morphology.
[17] R. Milo,et al. Dynamic Proteomics of Individual Cancer Cells in Response to a Drug , 2008, Science.
[18] Pornpimol Charoentong,et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks , 2009, Bioinform..
[19] David McDermott,et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. , 2007, The New England journal of medicine.
[20] J. Montero,et al. Inhibition of Src Family Kinases and Receptor Tyrosine Kinases by Dasatinib: Possible Combinations in Solid Tumors , 2011, Clinical Cancer Research.
[21] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[22] J. Uhm. Clonal selection drives genetic divergence of metastatic medulloblastoma , 2012 .
[23] Richard Durbin,et al. Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..
[24] C. Charbonneau,et al. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. , 2008, Cancer treatment reviews.
[25] F. Erdoğan,et al. Prognostic significance of morphologic parameters in renal cell carcinoma , 2004, International journal of clinical practice.
[26] M. Higashiyama,et al. Differences in chemosensitivity between primary and paired metastatic lung cancer tissues: In vitro analysis based on the collagen gel droplet embedded culture drug test (CD-DST). , 2012, Journal of thoracic disease.
[27] G. Hannon,et al. Patient-derived tumor xenografts: transforming clinical samples into mouse models. , 2013, Cancer research.
[28] N. Cox,et al. Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines , 2014, Genome Biology.
[29] Mark T. W. Ebbert,et al. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes , 2011, Nature Medicine.
[30] Victor Raskin,et al. School of Mechanical Engineering , 2007 .
[31] Pablo Cingolani,et al. © 2012 Landes Bioscience. Do not distribute. , 2022 .
[32] T. Choueiri,et al. External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study. , 2013, The Lancet. Oncology.
[33] Y. Nagashima,et al. Contribution of the Src family of kinases to the appearance of malignant phenotypes in renal cancer cells , 2005, Molecular carcinogenesis.
[34] L. Gunaratnam,et al. Silencing of epidermal growth factor receptor suppresses hypoxia-inducible factor-2-driven VHL-/- renal cancer. , 2005, Cancer research.
[35] T. Hudson,et al. The Genetic Basis for Cancer Treatment Decisions , 2012, Cell.
[36] Thomas D. Wu,et al. A comprehensive transcriptional portrait of human cancer cell lines , 2014, Nature Biotechnology.
[37] G. Getz,et al. Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.
[38] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[39] F. Waldman,et al. Epidermal growth factor receptor expression is associated with rapid tumor cell proliferation in renal cell carcinoma. , 1997, Human pathology.
[40] Nci Dream Community. A community effort to assess and improve drug sensitivity prediction algorithms , 2014 .
[41] Steven J. M. Jones,et al. Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.
[42] Laura M. Heiser,et al. A community effort to assess and improve drug sensitivity prediction algorithms , 2014, Nature Biotechnology.
[43] P. Sorger,et al. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis , 2009, Nature.
[44] A. McKenna,et al. Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.
[45] Cheng Li,et al. Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.
[46] Marie Joseph,et al. Gene Signatures of Progression and Metastasis in Renal Cell Cancer , 2005, Clinical Cancer Research.
[47] Juergen Friedrich,et al. Spheroid-based drug screen: considerations and practical approach , 2009, Nature Protocols.
[48] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[49] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[50] S. Pomer,et al. Concomitant overexpression of the EGFR and erbB‐2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis , 1996, International journal of cancer.
[51] H. Seol,et al. Patient-Derived Xenografts from Non–Small Cell Lung Cancer Brain Metastases Are Valuable Translational Platforms for the Development of Personalized Targeted Therapy , 2014, Clinical Cancer Research.
[52] Shawn M. Gillespie,et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.
[53] N. Navin. Cancer genomics: one cell at a time , 2014, Genome Biology.
[54] P. A. Futreal,et al. Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing , 2014, Nature Genetics.
[55] J. Yokota,et al. Molecular footprints of human lung cancer progression , 2004, Cancer science.
[56] Michael L. Gatza,et al. A pathway-based classification of human breast cancer , 2010, Proceedings of the National Academy of Sciences.
[57] Sang Hyun Yi,et al. High-throughput screening (HTS) of anticancer drug efficacy on a micropillar/microwell chip platform. , 2014, Analytical chemistry.
[58] R. Kamm,et al. Microfluidic assay for simultaneous culture of multiple cell types on surfaces or within hydrogels , 2012, Nature Protocols.
[59] Justin Guinney,et al. GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.
[60] R. Arceci. Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing , 2012 .
[61] R. Motzer,et al. Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial , 2011, The Lancet.
[62] W. Linehan,et al. The genetic basis of kidney cancer: a metabolic disease , 2010, Nature Reviews Urology.
[63] Jordan C. Ciciliano,et al. Corrigendum: RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis , 2012, Nature.
[64] Joshua F. McMichael,et al. Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft , 2010, Nature.
[65] Yang Zhao,et al. EMT Phenotype is Induced by Increased Src Kinase Activity via Src-Mediated Caspase-8 Phosphorylation , 2012, Cellular Physiology and Biochemistry.
[66] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[67] T. Pawson,et al. Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer , 2008, British Journal of Cancer.
[68] Steven J. M. Jones,et al. Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.
[69] Andrew M. K. Brown,et al. Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer , 2013, Science.
[70] D. Trump. Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: A randomized Phase III clinical trial , 2008 .
[71] Do-Hyun Nam,et al. Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells , 2015, Genome Biology.
[72] H. Moch,et al. Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression , 2013, British Journal of Cancer.
[73] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[74] Michael B Atkins,et al. Resistance to targeted therapy in renal-cell carcinoma. , 2009, The Lancet. Oncology.